Equity - Summary of the Warrants (Details) - $ / shares		Dec. 31, 2023	Jul. 31, 2023	May 18, 2023	Apr. 10, 2023
Stockholders Equity Details [Line Items]
Number of shares		7,070,627
Exercise price					$ 7.5
Dragasac Warrant
Stockholders Equity Details [Line Items]
Number of shares	[1]	652,981
Exercise price	[1]	$ 67.7
Expiration date	[1]	Mar. 16, 2025
Public Warrants
Stockholders Equity Details [Line Items]
Number of shares	[2]	1,437,447
Exercise price	[2]	$ 115
Expiration date	[2]	Jul. 16, 2026
Sponsor Warrants
Stockholders Equity Details [Line Items]
Number of shares	[2]	849,999
Exercise price	[2]	$ 115
Expiration date	[2]	Jul. 16, 2026
May 2022 PIPE Warrants
Stockholders Equity Details [Line Items]
Number of shares		405,405	405,405
Exercise price		$ 3.5
Expiration date		Oct. 10, 2028
March 2023 PIPE Warrants
Stockholders Equity Details [Line Items]
Number of shares		208,485
Exercise price		$ 30
Expiration date		Mar. 27, 2028
March 2023 PIPE Warrants (modified)
Stockholders Equity Details [Line Items]
Number of shares		729,698
Exercise price		$ 10
Expiration date		Mar. 27, 2028
March 2023 Loan Warrants
Stockholders Equity Details [Line Items]
Number of shares		75,000
Exercise price		$ 7.1
Expiration date		Mar. 17, 2028
April 2023 Registered Direct Warrants
Stockholders Equity Details [Line Items]
Number of shares		435,625
Exercise price		$ 7.5
Expiration date		Oct. 10, 2028
April 2023 Registered Direct Warrants (Modified)
Stockholders Equity Details [Line Items]
Number of shares		487,451	487,451
Exercise price		$ 3.5
Expiration date		Oct. 10, 2028
May 2023 PIPE Warrants
Stockholders Equity Details [Line Items]
Number of shares		581,394
Exercise price		$ 10		$ 10
Expiration date		May 17, 2028		May 18, 2028
June 2023 Warrants
Stockholders Equity Details [Line Items]
Number of shares		50,000
Exercise price		$ 8.1
Expiration date		Jun. 20, 2028
June 2023 Loan Warrants
Stockholders Equity Details [Line Items]
Number of shares		300,000
Exercise price		$ 8.1
Expiration date		Jun. 20, 2028
July 2023 Registered Direct Warrants
Stockholders Equity Details [Line Items]
Number of shares		857,142
Exercise price		$ 3.5
Expiration date		Jan. 31, 2029

[1] The exercise price is the lesser of $67.70 per share or 80% of either (i) the value attributed to one share of Legacy Celularity Series B Preferred Stock upon consummation of a change in control or the closing of a strategic transaction or (ii) the price at which one share of common stock is sold to the public market in an initial public offering.

[2] The number of Public Warrants and Sponsor Warrants outstanding was not adjusted for the reverse stock split. There are 14,374,478 Public Warrants and 8,499,999 Sponsor Warrants outstanding. After the reverse stock split, the number of warrants outstanding remains the same. However, each outstanding warrant is now exercisable for one-tenth of a share of Class A common stock, and the exercise price per share was adjusted to $115.00 as a result of the split.